Access Denied: Medicine, Trust, and Experimental Treatments

Network Node: 
Mon., Mar. 14, 2011, 7:00pm

Toronto: Science and its Publics National Lecture Series Presents Part 4:
Access Denied: Medicine, Trust, and Experimental Treatments
Live chat instructions for streaming          here

Monday, March 14, 2011, 7 pm EDT
Northrop Frye Hall Room 3
Victoria College, University of Toronto
Toronto, Ont.
Live streamed at
Facebook event             here

Do patients with advanced disease have a right to new and unproven medications?  Patient advocates in HIV, cancer, and most recently, multiple sclerosis, have pressed for easing access to experimental therapies.  Yet, such efforts come in direct conflict with policies that protect patients from fraudulent or unwarranted health claims.  In this public forum, we will examine the intersections of science, patient self-determination, and patient protection.

This event marks the fourth part of a multi-part national series on Science and its Publics created by the Situating Science Strategic Knowledge Cluster, ( and the Canadian Centre for Ethics in Public Affairs, (


Dr. Jonathan Kimmelman, Associate Professor, Biomedical Ethics Unit, Social Studies of Medicine, Faculty of Medicine McGill University

Dr. Kerry Bowman, Bioethicist, University of Toronto and Clinical Ethicist, Mount Sinai Hospital, Toronto

Dr. Daniel Selchen, Chief of Neurology, St. Michael’s Hospital, and Consultant, MS Clinic, Toronto (Replacing Dr. Samuel Ludwin)

Dr. Anthony Lang, Senior Scientist, Division of Patient Based Clinical Research, Toronto Western Research Institute and Jack Clark Chair, University of Toronto Centre for Research

This presentation is supported by the Institute for the History and Philosophy of Science and Technology, York University, Neuroscience Program and the Joint Centre for Bioethics, University of Toronto

Free admission

Reception to follow

Click here for more on the Lecture Series